Introduction to Cannara Biotech Inc.
Cannara Biotech Inc. has been making waves in the cannabis industry, positioning itself as a leader in the production of premium-grade cannabis and derivative products. This vertically integrated company operates two expansive facilities in Québec, covering a substantial 1,650,000 square feet. With an impressive potential annual cultivation output of 100,000 kilograms, Cannara is committed to delivering affordable cannabis products of the highest quality to its customers.
Participation in the Ventum Canadian Cannabis Conference
As part of its ongoing efforts to enhance market presence and investor engagement, Cannara Biotech is thrilled to announce its participation in the upcoming Ventum Capital Markets Canadian Cannabis Conference. The event is scheduled to take place on March 12, where Cannara’s CEO Zohar Krivorot and CFO Nicholas Sosiak will lead a presentation highlighting the company's recent achievements and future strategies.
Insights from Company Leaders
During the conference, Cannara's leadership will discuss their remarkable financial performance and growth trajectory within the competitive cannabis market. Mr. Krivorot stated, "Cannara Biotech is excited to participate in the Ventum Canadian Cannabis Conference, where we will showcase our impressive financial performance, rapid market share growth, and unmatched cost advantages through our Québec operations." He emphasized that while many competitors are struggling to achieve profitability, Cannara is poised for continued success, scaling efficiently and maintaining robust profit margins.
Engaging with Investors
The conference will provide an opportunity for Cannara to engage directly with investors. Audience members will not only learn about the company’s strategies but will also have the chance to pose questions to the executive team, allowing for a more dynamic interaction. This initiative demonstrates Cannara’s commitment to transparency and accessibility, ensuring that investors are well-informed about the company’s direction and goals.
How to Attend
If you're interested in joining Cannara’s presentation at the Ventum Conference, the registration information is readily available. The engagement is not just an opportunity to hear about Cannara's success but a crucial chance for investors to understand the future outlook of the cannabis industry in Canada.
Contact Information for Further Inquiries
Cannara Biotech encourages anyone with questions or who desires more information to reach out directly to their leadership team. For inquiries, you can contact Nicholas Sosiak, the Chief Financial Officer, or Zohar Krivorot, the President and CEO. They are available via email and are eager to assist those interested in the company’s operations and future.
About Cannara Biotech Inc.
Cannara is known for its rigorous quality control measures, ensuring that all cannabis products meet high standards. The company capitalizes on Québec's low electricity costs, which plays a crucial role in producing premium cannabis at sustainable prices. By doing so, Cannara not only meets the needs of the market but also contributes positively to the local economy.
Frequently Asked Questions
What is Cannara Biotech known for?
Cannara Biotech is recognized for producing premium-grade cannabis and derivative products at competitive prices from their large facilities in Québec.
When is Cannara Biotech presenting at the Ventum Conference?
Cannara Biotech is set to present at the Ventum Canadian Cannabis Conference on March 12, focusing on their growth and market strategies.
Who will be speaking on behalf of Cannara Biotech?
Zohar Krivorot (CEO) and Nicholas Sosiak (CFO) will lead the presentation and engage with investors.
How can one register to attend the event?
Interested individuals can register for the conference through provided audience registration links.
Where can I find more information on Cannara Biotech?
More information about Cannara Biotech can be found on their official website, which provides updates on their operations and product offerings.
